INTA vs TMO · rev $577.8M vs P/E 24, rev $44.56B
Intapp Inc (INTA) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Intapp Inc (INTA) is a software - application company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported INTA revenue for 2026-06-30 was $577.8M. Net income was -$41.3M. Revenue was up 14.6% from 2025-06-30 to 2026-06-30. INTA currently screens at market cap $3.89B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
INTA currently screens at market cap $3.89B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the INTA and TMO stock pages for the full models.
Not investment advice.